4.27
+0(+0.00%)
Currency In USD
| Previous Close | 4.27 |
| Open | 4.33 |
| Day High | 4.39 |
| Day Low | 4.27 |
| 52-Week High | 21.4 |
| 52-Week Low | 2.77 |
| Volume | 58,954 |
| Average Volume | 1.56M |
| Market Cap | 7.94M |
| PE | -1.06 |
| EPS | -4.02 |
| Moving Average 50 Days | 8.47 |
| Moving Average 200 Days | 7.41 |
| Change | 0 |
If you invested $1000 in Neuphoria Therapeutics Inc. (NEUP) since IPO date, it would be worth $24.16 as of December 07, 2025 at a share price of $4.27. Whereas If you bought $1000 worth of Neuphoria Therapeutics Inc. (NEUP) shares 3 years ago, it would be worth $57.86 as of December 07, 2025 at a share price of $4.27.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Neuphoria Responds to Lynx1’s Revised Indication of Interest at a Reduced Price and Premium
GlobeNewswire Inc.
Dec 04, 2025 1:00 PM GMT
Neuphoria Will Continue its Well-Planned Strategic Alternatives Review, Which has Garnered Significant Positive Interest Urges Stockholders to Vote “FOR” BOTH of Neuphoria’s Nominees on the WHITE Proxy Card BURLINGTON, Mass., Dec. 04, 2025 (GLOBE N
Neuphoria Provides Facts, Exposes False Narratives in Response to Lynx1 Fictions
GlobeNewswire Inc.
Dec 01, 2025 1:00 PM GMT
BURLINGTON, Mass., Dec. 01, 2025 (GLOBE NEWSWIRE) -- Neuphoria Therapeutics Inc. (“Neuphoria” or the “Company”) (NASDAQ: NEUP), a clinical-stage biotechnology company dedicated to developing therapies that address the complex needs of individuals a
Neuphoria Therapeutics Inc. Sends Letter to Stockholders
GlobeNewswire Inc.
Nov 24, 2025 1:00 PM GMT
Files Definitive Proxy Statement for 2025 Annual Meeting of Stockholders Urges Stockholders to Vote “FOR” BOTH Neuphoria Therapeutics Nominees on WHITE Proxy Card BURLINGTON, Mass., Nov. 24, 2025 (GLOBE NEWSWIRE) -- Neuphoria Therapeutics Inc. (“Ne